STAAR Surgical Ends Merger with Alcon After Shareholder Vote Fails

STAAR Surgical has terminated its merger agreement with Alcon after failing to secure enough shareholder votes, despite an increased $1.6 billion offer. This decision leaves STAAR to navigate standalone operations amid declining revenue and collapsed China sales.

洞察:
STAAR Surgical Company announced on January 6 that it has terminated its merger agreement with Alcon Inc. after failing to secure sufficient shareholder approval. The decision comes despite Alcon's increased offer of $1.6 billion, up from an original valuation of $1.5 billion, which was insufficient to sway shareholders in favor of the deal.
The logo of Alcon is seen at the company's French headquarters in Rueil-Malmaison, France, August 17, 2019. REUTERS/Charles Platiau
The logo of Alcon is seen at the company's French headquarters in Rueil-Malmaison, France, August 17, 2019. REUTERS/Charles Platiau
IUX24

IUX24 提供深度財經、經濟與投資資訊,借助 AI 挖掘全球市場中最重要的訊號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場資料、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易訊號或經紀服務。投資涉及風險,使用者在做出投資決定前應審慎評估相關資訊。